A few points, in my opinion of the 2014 report
1. They had a gain of $350,000 added to income for the sale of warrants in 2013 Q4. They did not have any gain this year. So, going forward, earnings will compare. Add in the $350,000 to 2014 earnings of the warrant income missed and earnings for Q4 would have been .052 per share. 2014 would have had profits of .168 per share, compared to 2013 for the year, if they had a warrant gain like in 2013. But assuming no warrant gains in 2015, the .15 per share stands. Give APT a 25 PE and the stock should be $2.75. So, we are close.
2. Infection control sales could fall a bit in 2015. The Ebola scare probably got hospitals around the world more suits, and new competition for the big companies might get tougher in 2015.
3. I feel the stock is fairly valued here, but I feel it could be a buyout candidate with the great mix of products.
4. The share buyback, tough to figure it's worth until they do it. and IF they do it.
I'd call it a hold, but I am a trader and see other opportunities. However, I don't see any downside from here and I could see it higher in the next couple of weeks.
News 
Market Data 
Discover 
